Forbes -
26 Feb 2021 17:40

The stock price of Emergent Biosolutions, a biopharmaceutical company focused on vaccines and antibody therapeutics for infectious diseases, and opioid overdoses, has seen a 17% drop over the last ten trading days, while it's down 19% over the last five trading days, and we believe the stock may...
Share this Article